Skip to main content
Clinical Trials/NCT02534181
NCT02534181
Withdrawn
Phase 2

Refeeding Syndrome in Cancer Patients Admitted to Adult Intensive Care Unit

University of Sao Paulo0 sitesJuly 2015

Overview

Phase
Phase 2
Intervention
Caloric Management Protocol
Conditions
Refeeding Syndrome
Sponsor
University of Sao Paulo
Primary Endpoint
Logistic Organ Dysfunction Score
Status
Withdrawn
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to evaluate whether a nutritional strategy is effective in critically ill patients with cancer diagnosed with refeeding syndrome.

Detailed Description

Refeeding syndrome is a clinical entity triggered by the introduction of calories in chronically undernourished patients. A number of organs may be affected due to imbalance of fluids and electrolytes. In the intensive care setting, there are no formal guidelines to recommend the appropriate treatment of this condition. The aim of this study is to evaluate the implementation of a nutritional protocol to address cancer patients admitted to the ICU with refeeding syndrome.

Registry
clinicaltrials.gov
Start Date
July 2015
End Date
February 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eduardo Atsushi Osawa

ICU Consultant Physician

University of Sao Paulo

Eligibility Criteria

Inclusion Criteria

  • Initiation of any type of nutrition (enteral, parenteral or glucose solution of at least 10% concentration) in the ICU in the last 48 hours;
  • Reduction of serum phosphorus to a level below 2.5mg/dL with a drop above 0.5mg/dL compared to a previous measurement;
  • Caloric intake greater than 500kcal in the last 24 hours;
  • Central venous access for electrolyte replacement;
  • Signature of the informed consent form.

Exclusion Criteria

  • Use of enteral or parenteral nutrition before ICU admission;
  • Prediction of ICU discharge in the following 2 days;
  • End-stage renal disease;
  • Admission for diabetic ketoacidosis or hyperosmolar hyperglycemic state;
  • Recent treatment of hyperphosphatemia;
  • Parathyroidectomy surgery;
  • Participation in another study;
  • Refusal to participate in the study.

Arms & Interventions

Intervention group

Patients will undergo a caloric management protocol: Days 1 and 2: 1. Reduction of caloric intake to 5kcal/kg/day; 2. Replacement of serum phosforus, potassium and magnesium; 3. Administration of 100mg intravenous thiamine, vitamins and microelements. From day 3: 1. If serum phosphorus \< 2.5mg/dL, protocol will be followed according to day 2; 2. If serum phosphorus \> 2.5mg/dL, a gradual increase to target caloric intake will ensue.

Intervention: Caloric Management Protocol

Outcomes

Primary Outcomes

Logistic Organ Dysfunction Score

Time Frame: 72 hours

Score of the number and severity of organ failures during ICU stay

Secondary Outcomes

  • ICU length of stay(30 days)
  • Acute ischemic stroke(30 days)
  • Seizures(30 days)
  • Adverse events(30 days)
  • Hospital length of stay(30 days)
  • Days in mechanical ventilation(30 days)
  • Days in vasopressor therapy(30 days)
  • Cardiovascular events(30 days)
  • Delirium(30 days)
  • Acute kidney injury(30 days)
  • Mortality(30 days)
  • Renal Replacement Therapy(30 days)

Similar Trials